CervoMed (CRVO) has a profit margin of -326822.53%, below the Healthcare sector average of 19.13%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for CRVO is -326822.53% as of September 2026. That compares with -1229.87% in the prior-year period — down 26473.7% year over year. That is below the Healthcare sector average of 19.13%. Investors often review this figure alongside CervoMed's historical trend and sector peers before judging valuation or financial health.
Over the past year, CRVO's profit margin moved from -1229.87% to -326822.53% — a 26473.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in CervoMed's valuation or profitability profile.
Against Healthcare companies, CRVO currently prints -326822.53% for profit margin, while the sector average sits near 19.13%. That is roughly 1708413.2% below the sector mean. Large gaps often invite a closer look at CervoMed's growth, margins, and balance sheet.
Profit Margin shows how effectively CervoMed converts resources into returns. At -326822.53%, CRVO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1229.87% in the prior-year period — down 26473.7% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting CRVO's profit margin (-326822.53%), review year-over-year change from -1229.87%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.